# clm_CF6C0D5C4B30

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: revenue  
value: 4,860,427,000 United States dollar  
valid_from: 2016-12-31  
valid_to: 2017-12-31  
published: 2017-02-09  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_246434942F91  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals revenue: 4,860,427,000 United States dollar", as of 2016-12-31 (until 2017-12-31). Claim clm_CF6C0D5C4B30, https://asof.is/claim/clm_CF6C0D5C4B30, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Revenues in 10-K FY2016, filed 2017-02-09  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217617000008/0001532176-17-000008-index.htm (primary, SEC EDGAR 10-K FY2016, published 2017-02-09)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | revenue | 4,103,728,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_CF6C0D5C4B30](/claim/clm_CF6C0D5C4B30.md) | [clm_DA3C150446BB](/claim/clm_DA3C150446BB.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.